ASCM_PETAA
ID ASCM_PETAA Reviewed; 459 AA.
AC P0DOW1;
DT 30-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT 30-NOV-2016, sequence version 1.
DT 03-AUG-2022, entry version 12.
DE RecName: Full=Asperlicin C monooxygenase {ECO:0000305};
DE EC=1.14.13.216 {ECO:0000269|PubMed:23030663};
GN Name=aspB {ECO:0000303|PubMed:23030663};
OS Petromyces alliaceus (Aspergillus alliaceus).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus.
OX NCBI_TaxID=209559;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP COFACTOR.
RC STRAIN=ATCC 20656 / MF4925;
RX PubMed=23030663; DOI=10.1021/ja308371z;
RA Haynes S.W., Gao X., Tang Y., Walsh C.T.;
RT "Assembly of asperlicin peptidyl alkaloids from anthranilate and
RT tryptophan: a two-enzyme pathway generates heptacyclic scaffold complexity
RT in asperlicin E.";
RL J. Am. Chem. Soc. 134:17444-17447(2012).
CC -!- FUNCTION: Catalyzes the conversion of asperlicin A to form asperlicin
CC E, a potent cholecystokinin receptor CCK(A) antagonist.
CC {ECO:0000269|PubMed:23030663}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=asperlicin C + H(+) + NADPH + O2 = asperlicin E + H2O +
CC NADP(+); Xref=Rhea:RHEA:49056, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:15379, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC ChEBI:CHEBI:90903, ChEBI:CHEBI:90904; EC=1.14.13.216;
CC Evidence={ECO:0000269|PubMed:23030663};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=asperlicin C + H(+) + NADH + O2 = asperlicin E + H2O + NAD(+);
CC Xref=Rhea:RHEA:49052, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:15379, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC ChEBI:CHEBI:90903, ChEBI:CHEBI:90904; EC=1.14.13.216;
CC Evidence={ECO:0000269|PubMed:23030663};
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692;
CC Evidence={ECO:0000303|PubMed:23030663};
CC -!- SIMILARITY: Belongs to the paxM FAD-dependent monooxygenase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DOW1; -.
DR SMR; P0DOW1; -.
DR GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR Gene3D; 3.50.50.60; -; 1.
DR InterPro; IPR002938; FAD-bd.
DR InterPro; IPR036188; FAD/NAD-bd_sf.
DR Pfam; PF01494; FAD_binding_3; 1.
DR SUPFAM; SSF51905; SSF51905; 1.
PE 1: Evidence at protein level;
KW FAD; Flavoprotein; Monooxygenase; NAD; NADP; Oxidoreductase.
FT CHAIN 1..459
FT /note="Asperlicin C monooxygenase"
FT /id="PRO_0000438497"
FT BINDING 30
FT /ligand="FAD"
FT /ligand_id="ChEBI:CHEBI:57692"
FT /evidence="ECO:0000250|UniProtKB:A6T923"
FT BINDING 323
FT /ligand="FAD"
FT /ligand_id="ChEBI:CHEBI:57692"
FT /evidence="ECO:0000250|UniProtKB:A6T923"
FT BINDING 333..337
FT /ligand="FAD"
FT /ligand_id="ChEBI:CHEBI:57692"
FT /evidence="ECO:0000250|UniProtKB:A6T923"
SQ SEQUENCE 459 AA; 50701 MW; 83C2E4FCC75E8062 CRC64;
MTMHVEVGPD STAPPHSSGI KVIIIGLGIG GLAAAIECHR KGHSVIAFDK AQELKPVGDG
IALAHNAVRV IEKWGKGTVG QELGRLSSRL NTTVIYDQTG RFIAEDKLDG FKAGEGHLLP
RGELSQVMYK HAKSLGIDMR LASEVDEYWE DENSAGVIVD GEKITADCVV ACDGVNSKAR
RHIIGYEPEL RSSGSCVFRG WMTTEEPLVG SHWLLSHTDQ ADQVKVFAGD GVHVLLSTIQ
HGKMVFWLCT HKDNDCYDRK KEAPPTPEVD GMIHLIRDWP MRGQIESTIR KTLAKNVMHY
PLLIREALSN WRSKGGRMVI IGDAAHPFLP VSGQGAAQAI EDAAVLAITL HLAGKEEVPL
ALHALEKIRL PRTALLQRSS LELERFWLNI DWPEVEKCPE LLTIPRPKWI HGHDCQTHAY
TEFAKVVSAI QMREEYHPLG GPRDSTNGES LLALLRQDT